Genomma Lab Internacional SAB de CV (LABB):企業の財務・戦略的SWOT分析

◆英語タイトル:Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2911
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:メキシコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genomma Lab Internacional SAB de CV (LABB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomma Lab Internacional SAB de CV (Genomma Lab) carries out the research, manufacture and commercialization of pharmaceuticals and other healthcare products. Its product portfolio includes wellness products, personal care products, dermo-cosmetic products and other halthcare products. The company offers anti-acne products, scar removal ointments, anti-acids, varicose vein treatments, analgesics, anti-fungal products, anti-inflammatory products, multivitamins, hemorrhoid treatments, colitis treatment products, shampoos, flu treatments and others. Genomma Lab also conducts research and development of drugs and personal care products to ensure safety, efficacy and quality of all its brands. It offers its products in Mexico, Latin America and the US. Genomma Lab is headquartered at Mexico City, Mexico.

Genomma Lab Internacional SAB de CV Key Recent Developments

Jul 25,2018: Genomma Lab Internacional reports second quarter 2018 results
Apr 25,2018: Genomma Lab Internacional Reports First Quarter 2018 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Genomma Lab Internacional SAB de CV – Key Facts 5
Genomma Lab Internacional SAB de CV – Key Employees 6
Genomma Lab Internacional SAB de CV – Major Products and Services 7
Genomma Lab Internacional SAB de CV – History 9
Genomma Lab Internacional SAB de CV – Company Statement 11
Genomma Lab Internacional SAB de CV – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Genomma Lab Internacional SAB de CV – Business Description 14
Genomma Lab Internacional SAB de CV – SWOT Analysis 15
SWOT Analysis – Overview 15
Genomma Lab Internacional SAB de CV – Strengths 15
Genomma Lab Internacional SAB de CV – Weaknesses 16
Genomma Lab Internacional SAB de CV – Opportunities 17
Genomma Lab Internacional SAB de CV – Threats 18
Genomma Lab Internacional SAB de CV – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Genomma Lab Internacional SAB de CV, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Jul 25, 2018: Genomma Lab Internacional reports second quarter 2018 results 30
Apr 25, 2018: Genomma Lab Internacional Reports First Quarter 2018 Results 31
Section 6 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Genomma Lab Internacional SAB de CV, Key Facts 5
Genomma Lab Internacional SAB de CV, Key Employees 6
Genomma Lab Internacional SAB de CV, Major Products and Services 7
Genomma Lab Internacional SAB de CV, History 9
Genomma Lab Internacional SAB de CV, Subsidiaries 12
Genomma Lab Internacional SAB de CV, Key Competitors 19
Genomma Lab Internacional SAB de CV, Ratios based on current share price 20
Genomma Lab Internacional SAB de CV, Annual Ratios 21
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...1) 22
Genomma Lab Internacional SAB de CV, Annual Ratios (Cont...2) 23
Genomma Lab Internacional SAB de CV, Interim Ratios 25
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Genomma Lab Internacional SAB de CV, Recent Deals Summary 29
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

List of Figures
Genomma Lab Internacional SAB de CV, Performance Chart (2013 - 2017) 24
Genomma Lab Internacional SAB de CV, Ratio Charts 26
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Genomma Lab Internacional SAB de CV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[Genomma Lab Internacional SAB de CV (LABB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Qassim Cement Company:企業の戦略・SWOT・財務情報
    Qassim Cement Company - Strategy, SWOT and Corporate Finance Report Summary Qassim Cement Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Austrian Airlines AG:企業の戦略・SWOT・財務情報
    Austrian Airlines AG - Strategy, SWOT and Corporate Finance Report Summary Austrian Airlines AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Goodwin Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd, is a biological contract development and manufacturing organization that offers antibody drug conjugates, radioimmunoconjugates, and other protein bioconjugates. The organization offers cell culture, purificati …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務情報
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Alamos Gold Inc:企業の戦略・SWOT・財務分析
    Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Chemours Company, LLC:戦略・SWOT・企業財務分析
    The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Swedish Orphan Biovitrum AB (SOBI):企業の財務・戦略的SWOT分析
    Swedish Orphan Biovitrum AB (SOBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • Firestone Diamonds plc:企業の戦略・SWOT・財務情報
    Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Welch Allyn Inc:企業の戦略的SWOT分析
    Welch Allyn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bangchak Corporation PCL (BCP):企業の財務・戦略的SWOT分析
    Bangchak Corporation PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bank of the Ryukyus Ltd:企業の戦略・SWOT・財務分析
    Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Career Education Corporation (CECO):企業の財務・戦略的SWOT分析
    Career Education Corporation (CECO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sitara Chemical Industries Ltd (SITC):企業の財務・戦略的SWOT分析
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Healthcare Services Group Inc (HCSG):企業の財務・戦略的SWOT分析
    Healthcare Services Group Inc (HCSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • WorleyParsons Ltd (WOR):電力:M&Aディール及び事業提携情報
    Summary WorleyParsons Ltd (WorleyParsons) is a provider of professional services. Its services cover the full lifecycle, from creating new assets to sustaining and enhancing operating assets. The company provides integrated solution for deepwater developments with the associated subsea, pipelines, r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆